皮肤冠状动脉干预在非老年人急性心肌梗塞:一个15年的基于人口的研究
Giancarlo Marenzi1, Nicola Cosentino2, Daniela Mele2
1Centro Cardiologico Monzino IRCCS, Via Parea 4, Milan, 20138, Italy. giancarlo.marenzi@ccfm.it.
Scientific reports
|January 8, 2026
概括
穿皮冠状动脉干预 (PCI) 在90岁以上的患者中显著降低了急性心肌梗塞 (AMI) 的死亡率和再住院. 这些好处无论患者的并发症如何,都会持续存在,支持PCI在老年人群中使用.
科学领域:
- 心脏病学 心脏病学
- 老年医学 老年医学
- 干预心脏病学 干预心脏病学
背景情况:
- 皮肤冠状动脉干预 (PCI) 在患有急性心肌梗塞 (AMI) 的老年患者 (90岁以上) 中的使用是有争议的,因为证据有限,多发病率高.
- 在这个特定的人群中,AMI的最佳治疗策略仍然不清楚.
研究的目的:
- 评估PCI对90岁及以上被诊断患有AMI的患者的影响和结果.
- 评估PCI与这种脆弱人群的住院死亡率,一年死亡率和再住院率的相关性.
主要方法:
- 伦巴第健康数据库 (意大利) 的回顾性分析,包括2003年至2018年期间住院的AMI患者.
- 通过调整的风险分析和倾向性得分匹配,对接受PCI和未接受PCI的患者之间的结果进行比较.
- 对ST升高心肌梗塞 (STEMI) 和非ST升高心肌梗塞 (NSTEMI) 患者的亚组分析.
主要成果:
- 在15954名AMI患者中的12%进行了PCI (平均年龄为92岁).
- 接受PCI治疗的患者在医院住院死亡率较低 (15%vs.23%) 和一年死亡率较低 (37%vs.58%).
- 对于急性心力衰竭或AMI的再住院率也在PCI接受者中降低了 (16%对21%),无论伴随疾病如何.
结论:
- 在90岁以上的AMI患者中,PCI与显著改善的生存率和减少的再入院相关.
- 在STEMI和NSTEMI亚组中观察到PCI的益处一致,并且独立于并发症.
- 这些发现支持在极年老年AMI患者中考虑PCI,挑战了以前关于其在这个年龄组的有用性的辩论.
关键词:
剧烈的心肌梗塞急性心肌梗塞更多相关视频
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
24.7K
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
3.7K
相关概念视频
01:30Acute Coronary Syndrome III: Diagnostic Studies
207
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
207
01:28Acute Coronary Syndrome IV: Interprofessional Care
214
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
214
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
183
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
183
01:30Acute Coronary Syndrome I: Introduction
785
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
785
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
223
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
223
01:26Coronary Artery Disease IV: Preventive Measures
580
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
580